NewAmsterdam Pharma (NAMS) Shares Issued (2022 - 2026)

NewAmsterdam Pharma (NAMS) has 5 years of Shares Issued data on file, last reported at $10.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 14.88% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $10.2 million (up 14.88% YoY), and the FY2025 full-year result was $20.6 million, up 8.39% from the prior year.
• Shares Issued eased to $10.2 million in Q1 2026, from $20.6 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $22.2 million in Q2 2025 to a low of $255243.0 in Q4 2023.
• A 5-year average of $12.3 million and a median of $10.2 million in 2026 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued plunged 97.76% in 2023 and soared 7355.27% in 2024, its largest moves.
• Tracing NAMS's Shares Issued over 5 years: stood at $11.4 million in 2022, then plunged by 97.76% to $255243.0 in 2023, then soared by 7355.27% to $19.0 million in 2024, then advanced by 8.39% to $20.6 million in 2025, then sank by 50.63% to $10.2 million in 2026.
• Business Quant data shows NAMS's Shares Issued at $10.2 million in Q1 2026, $20.6 million in Q4 2025, and $10.1 million in Q3 2025.